norUrsodeoxycholic Acid vs Placebo in PSC

Clinical trial NCT03872921 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03872921
Sponsor: Dr. Falk Pharma GmbH
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Primary Sclerosing Cholangitis

Start date: 2018-02-08
Primary completion: 2025-01-01
Enrollment: 303

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.